Impilo Therapeutics Launches to Enable Nucleic Acid-Based Medicines to Effectively Treat Solid Tumor Cancers
SAN DIEGO, Aug. 15, 2023 /PRNewswire/ -- Impilo Therapeutics, Inc. , a privately held drug discovery and development company, today announced that it has launched with the mission to enable nucleic... -Today at 08:31 am- MarketScreener
Source: marketscreener.com